The di-peptide Trp-His activates AMP-activated protein kinase and enhances glucose uptake independently of insulin in L6 myotubes

FEBS Open Bio

Volumn 4, Issue , 2014, Pages 898-904

  Soga, Minoru ^a   Ohashi, Ayaka ^a   Taniguchi, Megumi ^a   Matsui, Toshiro ^b   Tsuda, Takanori ^a  

^a CHUBU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

AMP activated protein kinase; Glucose transporter 4; LKB1; Peptide transporter; Trp His

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; INSULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; GLUCOSE TRANSPORT; MALE; MYOTUBE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT;

EID: 84910045140     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2014.10.008     Document Type: Article

References (41)

1. Shepherd P.R., Kahn B.B. Glucose transporters and insulin action: implications for insulin resistance and diabetes mellitus. N. Engl. J. Med. 1999, 341:248-257.
2. Hawley S.A., Davison M., Woods A., Davies S.P., Beri R.K., Carlinq D., et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996, 271:27879-27887.
3. Hardie D.G. Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. FEBS Lett. 2008, 582:81-89.
4. Kahn B.B., Alquier T., Carling D., Hardie D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1:15-25.
5. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108:1167-1174.
6. Fryer L.G., Parbu-Patel A., Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002, 277:25226-25232.
7. Merrill G.F., Kurth E.J., Hardie D.G., Winder W.W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997, 273:1107-1112.
8. Takikawa M., Inoue S., Horio F., Tsuda T. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J. Nutr. 2010, 140:527-533.
9. Takikawa M., Kumagai A., Hirata H., Soga M., Yamashita Y., Ueda M., et al. 10-Hydroxy-2-decenoic acid, a unique medium-chain fatty acid, activates 5'-AMP-activated protein kinase in L6 myotubes and mice. Mol. Nutr. Food Res. 2013, 57:1794-1802.
10. Um J.H., Park S.J., Kang H., Yang S., Foretz M., McBurney M.W., et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
11. Tanaka M., Tokuyasu M., Matsui T., Matsumoto K. Endothelium-independent vasodilation effect of di- and tri-peptides in thoracic aorta of Sprague-Dawley rats. Life Sci. 2008, 82:869-875.
12. Ansurudeen I., Sunkari V.G., Grünler J., Peters V., Schmitt C.P., Catrina S.B., et al. Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes. Amino Acids 2012, 43:127-134.
13. Nongonierma A.B., FitzGerald R.J. Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates. Peptides 2013, 39:157-163.
14. Yanagisawa M., Sugiya M., Iijima H., Nakagome I., Hirono S., Tsuda T. Genistein and daidzein, typical soy isoflavones, inhibit TNF-α-mediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Mol. Nutr. Food Res. 2012, 56:1783-1793.
15. Mahadev K., Wu X., Zilbering A., Zhu L., Lawrence J.T., Goldstein B.J. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem. 2001, 276:48662-48669.
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
17. Tsuda T., Ueno Y., Aoki H., Koda T., Horio F., Takahashi N., et al. Anthocyanin enhances adipocytokine secretion and adipocyte-specific gene expression in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 2004, 316:149-157.
18. Nishiumi S., Ashida H. Rapid preparation of a plasma membrane fraction from adipocytes and muscle cells: application to detection of translocated glucose transporter 4 on the plasma membrane. Biosci. Biotechnol. Biochem. 2007, 71:2343-2346.
19. Yamamoto N., Ueda M., Sato T., Kawasaki K., Sawada K., Kawabata K., et al. Measurement of glucose uptake in cultured cells. Curr. Protoc. Pharmacol. 2011, 12. 12.14.1-12.14.22.
20. 2+/calmodulin-dependent kinase II activation. Biochem. Biophys. Res. Commun. 2013, 435:165-170.
21. Urttiac A., Sadée W., Johns S.J. Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variant. AAPS Pharmsci. 2001, 3:66-79.
22. Groneberg D.A., Nickolaus M., Springer J., Döring F., Daniel H., Fischer A. Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am. J. Pathol. 2001, 158:707-714.
23. Romano A., Barca A., Kottra G., Daniel H., Storelli C., Verri T. Functional expression of SLC15 peptide transporters in rat thyroid follicular cells. Mol. Cell. Endocrinol. 2010, 315:174-181.
24. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2005, 2:9-19.
25. Sanders M.J., Grondin P.O., Hegarty B.D., Snowden M.A., Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem. J. 2007, 403:139-148.
26. Oakhill J.S., Chen Z.P., Scott J.W., Steel R., Castelli L.A., Ling N., et al. β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK). Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19237-19241.
27. 2+/calmodulin-dependent protein kinase II. Int. J. Biochem. Cell Biol. 2012, 15:1321-1330.
28. 2+-dependent signaling pathways regulating FA uptake and oxidation in contracting rodent muscle. J. Appl. Physiol. 2008, 104:1366-1373.
29. Illario M., Monaco S., Cavallo A.L., Esposito I., Formisan P., D'Andrea L., et al. Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake. Cell. Signal. 2009, 21:786-792.
30. 2+/calmodulin-dependent protein kinase II in L6 myotubes. Cell. Signal. 2012, 24:302-308.
31. Daniel H., Kottra G. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflüg. Arch. 2004, 447:610-618.
32. 2+ channels. Peptides 2010, 31:2060-2066.
33. 2+ channels in rat vascular smooth muscle cells. FEBS Open Bio 2012, 2:83-88.
34. Sung J.Y., Choi H.C. Nifedipine inhibits vascular smooth muscle cell proliferation and reactive oxygen species production through AMP-activated protein kinase signaling pathway. Vasc. Pharmacol. 2012, 56:1-8.
35. Morifuji M., Koga J., Kawanaka K., Higuchi M. Branched-chain amino acid-containing dipeptides, identified from whey protein hydrolysates, stimulate glucose uptake rate in L6 myotubes and isolated skeletal muscles. J. Nutr. Sci. Vitaminol. 2009, 55:81-86.
36. Viollet B., Guigas B., Garcia S.N., Leclerc J., Foretz M., Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clin. Sci. 2012, 122:253-270.
37. Kamal M.A., Jiang H., Keep R.F., Smith D.E. Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R986-R991.
38. Kubomura D., Matahira Y., Masui A., Matsuda H. Intestinal absorption and blood clearance of l-histidine-related compounds after ingestion of anserine in humans and comparison to anserine-containing diets. J. Agric. Food Chem. 2009, 57:1781-1785.
39. Adibi S.A. The oligopeptide transporter (Pept-1) in human intestine: biology and function. Gastroenterology 1997, 133:332-340.
40. Gardner M.L., Illingworth K.M., Kelleher J., Wood D. Intestinal absorption of the intact peptide carnosine in man, and comparison with intestinal permeability to lactulose. J. Physiol. 1991, 439:411-422.
41. Matsui T., Sato M., Tanaka M., Yamada Y., Watanabe S., Fujimoto Y., et al. Vasodilating dipeptide Trp-His can prevent atherosclerosis in apo E-deficient mice. Br. J. Nutr. 2010, 103:309-313.